Reporting and Prevention Guidelines for Cervical Cancer
Date: 02/04/22
In 2022, the American Cancer Society estimates that in the state of Texas there will be 1,500 new cases of invasive cervical cancer, and approximately 370 women will die from cervical cancer. Texas women will account for 11% of newly diagnosed cases and 9% of deaths. When detected early, cervical cancer is one of the most successfully treatable cancers.
Regular Pap testing is the most reliable and effective way to screen for cervical cancer. Early detection can help avoid delays in diagnosis and increase the chances of successful treatment. It can also prevent pre-cancer from turning into cervical cancer. Providers can help Superior members by using the early detection methods outlined in the tables below.
AGE | PAP/HUMAN PAPILLOMA VIRUS (HPV) TESTS |
|---|---|
Females, 21 - 64 years of age | Pap test every 3 years |
Females, 30 - 64 years of age | Pap test every 5 years when combined with HPV test HPV testing every 5 years Pap test every 3 years for those who opt not to have HPV combined testing |
The Human Papillomavirus (HPV) vaccination can also protect young girls against most cervical, vaginal and vulvar cancers caused by HPV.
Recommendations on HPV vaccinations for all members are outlined in the table below.
AGE | TYPE OF VACCINATION | SECOND DOSE | THIRD DOSE |
|---|---|---|---|
All members, 9 - 14 years of age | 2-dose vaccination series | Within 6-12 months after the initial dose
| N/A |
All members, 15 - 26 years of age | 3-dose vaccination series | Within 1-2 months after the initial dose | Within 6 months after the second dose |
Please note: Women who have been vaccinated for HPV will still need regular Pap tests.
For additional information on the guidelines above, please visit Superior’s Immunization Toolkit.
For reporting purposes, at least 2 or 3 HPV vaccines with different dates of service on or between the member’s 9th and 13th birthdays must be documented as administered. For the 2-dose vaccination series, there must be at least 146 days between the first and second vaccine doses.
As a reminder, Superior reports annually on the percentage of members, women 21 to 64 years of age, who are screened for cervical cancer. Superior also reports on the percentage of adolescents 13 years of age who have completed the HPV vaccine series by their 13th birthday.
To see more information on the stats and guidelines mentioned above, as well as to find more information on cervical cancer screening, please visit the American Cancer Society.